Will Evelo Biosciences Differentiated SINTAX approach pay off?
Evelo Biosciences, Inc. (NASDAQ: EVLO) is focused on developing innovative oral biologics that target cells in the intestines for the treatment of a range of inflammatory diseases and cancer. The Company’s approach is to develop systemically acting biologics that can act on the cells in...
